This observation prompted the investigators to suggest that mutations in the RING domain that disrupt the E3 ligase activity of BRCA1 are not linked to breast cancer predisposition, whereas those that disrupt the interaction with BARD1 are linked to tumor development [60]. This evidence concerns the gene BARD1 and breast carcinoma.